Summary
30 spleens from patients with biopsy proven primary osteomyelofibrosis were studied by histological and immunohistochemical methods. The presence of trilinear haematopoiesis along the splenic circulatory pathway supports the theory that the spleen acquires haematopoietic precursor cells by filtration of the peripheral blood. In addition, impairment of intrasplenic circulation with subsequent red pulp congestion, pulp cord fibrosis and haemophagocytosis is of importance for the pathogenesis of both marked splenic haematopoiesis and complications due to hypersplenism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aster RH (1966) Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia. J Clin Invest 45:645–657
Bouroncle BA, Doan CA (1962) Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients. Am J Med Sci 243:697–715
Castro-Malaspina H, Rabellino M, Yen A, Nachman RL, Moore MAS (1981) Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 57:781–787
Cordell JL, Falini B, Erber WN, Gosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219–229
Dameshek W (1951) Some speculations on the myeloproliferative syndromes. Blood 6:372–375
DiBella NJ, Silverstein MN, Hoagland HC (1974) Effect of splenectomy on teardrop-shaped erythrocytes in agnogenic myeloid metaplasia. Am J Clin Pathol 61:307–310
Goldman JM, Nolasco I (1983) The spleen in myeloproliferative disorders. Clin Haematol 12:505–516
Leder LD (1964) Über die selektive fermentcytochemische Darstellung von neutrophilen myeloischen Zellen und Gewebsmastzellen. Klin Wochenschr 42:553
Lewis SM (1985) Myelofibrosis: historical perspective. In: Lewis SM (ed) Myelofibrosis. Pathophysiology and clinical management. Marcel Dekker, New York, pp 1–13
Niles NR, Koler RD, Johnson RL, Smith DD, Dunlap WJ (1959) Myeloproliferative diseases: clinical and pathological study of 69 cases. Am J Clin Pathol 31:222–229
Palitzsch KD, Falk S, Müller H, Stutte HJ (1987) Splenic haematopoiesis in patients with cirrhosis of the liver. Virchows Arch [A] 411:179–183
Peters AM, Saverymuttu SH, Wonke B, Lewis SM, Lavender JP (1984) The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction. Br J Haematol 57:637–649
Pettit JE, Lewis SM, Williams ED, Grafton CA, Bowring CS, Glass HI (1976) Quantitative studies of splenic erythropoiesis in polycythaemia vera and myelofibrosis. Br J Haematol 34:465–475
Pitcock JA, Reinhard EH, Justus BW, Mendelsohn RS (1962) A clinical and patholgical study of 70 cases of myelofibrosis. Ann Intern Med 57:73–84
Rappaport H (1966) Tumors of the hematopoietic system. Armed Forces Institute of Pathology, Washington DC
Silverstein MN, ReMine WH (1979) Spenectomy in myeloid metaplasia. Blood 53:515–518
Szur L, Smith MD (1961) Red cell production and destruction in myelofibrosis. Br J Haematol 7:147–168
Tavassoli M, Weiss L (1973) An electron microscopic study of spleen in myelofibrosis with myeloid metaplasia. Blood 42:267–279
Thiele J, Hoeppner B, Zankovich, Fischer R (1989) Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia-correlations between clinical and morphological features. Virchows Arch [A] 415:191–202
Van Krieken JHJM, TeVelde J, Kleiverda K, Leenheers-Binnendijk L, Van de Velde CJH (1985) The human spleen; a histological study in splenectomy specimens embedded in methylmethacrylate. Histopathology 9:571–585
Wadenvik H, Denfors I, Kutti J (1987) Splenic blood flow and intrasplenic platelet kinetics in relation to spleen volume. Br J Haematol 67:181–185
Ward HP, Block MH (1971) The natural history of angogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with myeloproliferative syndrome. Medicine 50:357–420
Wintrobe MM, Lee GR, Boggs DR, Bithell TC, Foerster J, Athens JW, Luhens JN (1981) Clinical hematology. Lea and Febiger, Philadelphia, pp 1615–1630
Wolf BC, Neiman RS (1985) Myelofibrosis with myeloid metaplasia. Pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 65:803–809
Wolf BC, Neiman RS (1987) Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hematol Pathol 1:77–80
Wolf BC, Neiman RS (1989) Disorders of the spleen. Major problems in pathology, vol 20. Saunders, Philadelphia, p 173
Zhang B, Lewis SM (1989) The splenomegaly of myeloproliferative and lymphoproliferative disorders: splenic cellularity and vascularity. Eur J Haematol 43:63–66
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Falk, S., Mix, D. & Stutte, HJ. The spleen in osteomyelofibrosis. Vichows Archiv A Pathol Anat 416, 437–442 (1990). https://doi.org/10.1007/BF01605150
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01605150